Global Pig Vaccine Market Size By Technology, By Disease Indication, By End User, By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Pig Vaccine Market Size By Technology, By Disease Indication, By End User, By Geographic Scope And Forecast
Pig Vaccine Market Size And Forecast
Pig Vaccine Market size was valued at USD 1.67 Billion in 2023 and is projected to reach USD 3.71 Billion by 2031, growing at a CAGR of 10.50% during the forecast period 2024-2031.
Global Pig Vaccine Market Drivers
The market drivers for the Pig Vaccine Market can be influenced by various factors. These may include
- Disease Outbreaks The demand for pig vaccinations is greatly impacted by outbreaks of diseases including Foot-and-Mouth Disease (FMD), Porcine Reproductive and Respiratory Syndrome (PRRS), and African Swine Fever (ASF). In order to stop the spread of these outbreaks and reduce financial losses for the pig farming sector, vaccinations may become more important due to their severity and regularity.
- Growing Pig Production Pig production has increased in tandem with the rising demand for pork around the world. The demand for vaccines to safeguard the health and wellbeing of pigs and ensure maximum productivity and profitability for farmers is being driven by the development in pig farming.
- Government Regulations The market for pig vaccines is mostly driven by government regulations that demand vaccination programs to stop the spread of illnesses. In order to avoid disease outbreaks, protect the public’s health, and uphold food safety regulations, governments may mandate vaccination programs.
- Technological Developments The Pig Vaccine Market is growing as a result of developments in biotechnology and vaccine development methods. Adjuvants, subunit vaccinations, and recombinant DNA technologies are examples of innovations that have improved vaccine efficacy, safety, and convenience of administration, leading to increased uptake among pig farmers.
- Education And Awareness Raising pig farmers’ knowledge of the advantages of vaccinations for managing herds and preventing disease promotes market expansion. The demand for pig vaccines is fueled by educational programs launched by governmental bodies, veterinary associations, and vaccine producers. These programs assist in spreading knowledge about the value of vaccination.
- Globalization Of Trading As trading in pork products has expanded internationally, there is a greater chance that diseases will spread internationally. Countries may impose strict vaccination schedules and biosecurity measures to reduce this risk and guarantee the continuous flow of pork trade, which would increase demand for pig vaccines.
- Climate Change And Environmental Factors The prevalence and geographic spread of pig-related diseases can be impacted by climate change. Variations in temperature, precipitation patterns, and the proliferation of vector-borne diseases might have an impact on the dynamics of disease, hence requiring modifications in vaccination approaches and stimulating the need for pig vaccines in the market.
- Partnerships And Investments Research and development expenditures made by vaccine producers, in conjunction with strategic alliances and partnerships with academic institutions, governmental agencies, and international organizations, stimulate product development and innovation in the pig vaccination industry, increasing the variety of vaccines on the market and enhancing their effectiveness.
Global Pig Vaccine Market Restraints
Several factors can act as restraints or challenges for the Pig Vaccine Market. These may include
- Regulatory Obstacles Tight laws and lengthy approval procedures for the production and distribution of vaccines might impede market expansion.
- Limited KnowledgeThe expansion of the market may be hampered by pig farmers’ ignorance of the advantages and significance of vaccination.
- High Costs Developing, manufacturing, and distributing vaccines can be costly, especially for more recent and sophisticated formulations. This can have an impact on adoption rates, particularly in areas with low resources.
- Logistical Difficulties Farmers may find it difficult to obtain vaccines due to logistical issues, particularly when distributing them to isolated or rural areas.
- Disease Outbreaks Can Increase Demandfor vaccinations, but they can also cause supply chain disruptions and have an impact on the stability of the market.
- Competitive Environment The competition among vaccine producers may put pressure on prices and lower profit margins, which may hinder the expansion of the market.
- Ethical And Environmental Concerns The use of vaccinations in animal husbandry may raise ethical questions for some stakeholders. Environmental issues surrounding the production of vaccines and the disposal of waste may also function as a barrier.
- Emerging Alternatives The market expansion for pig vaccines may be hampered by the creation of substitute approaches to disease prevention and control, such as genetic selection for disease resistance.
- Trade Barriers Trade limitations and impediments may hinder the international flow of vaccines, hence influencing the expansion of the vaccine market in specific areas.
Global Pig Vaccine Market Segmentation Analysis
The Global Pig Vaccine Market is Segmented on the basis of Technology, Disease Indication, End User, And Geography.
Pig Vaccine Market, By Technology
- Inactivated Vaccines These vaccines contain killed viruses or bacteria, offering good safety but potentially weaker immunity than live vaccines.
- Live Attenuated Vaccines These vaccines contain weakened forms of viruses or bacteria, providing strong immunity but carrying a small risk of causing the disease themselves.
- Recombinant Vaccines These vaccines use genetic engineering to produce specific antigens, offering high purity and safety.
- Other Technologies Other vaccine technologies include toxoid vaccines, conjugate vaccines, and DNA vaccines.
Pig Vaccine Market, By Disease Indication
- Diarrhea This segment includes vaccines for various pig diarrheal diseases, such as rotavirus and E. coli.
- Swine Influenza This segment includes vaccines for different strains of swine influenza.
- Arthritis This segment includes vaccines for porcine circovirus-associated diseases (PCVAD) and other causes of arthritis in pigs.
- Bordetella Rhinitis This segment includes vaccines for Bordetella bronchiseptica, a bacterium causing respiratory problems in pigs.
- Other Disease Indications This segment includes vaccines for other important pig diseases, such as porcine parvovirus, leptospirosis, and foot-and-mouth disease.
Pig Vaccine Market, By End User
- Veterinary Hospitals & Clinics This segment includes veterinary practices that administer vaccines to pigs.
- Farms This segment includes pig farms that purchase and administer vaccines to their own animals.
- Other End Users This segment may include research institutions and government agencies involved in pig health.
Pig Vaccine Market, By Geography
- North America Market conditions and demand in the United States, Canada, and Mexico.
- Europe Analysis of the Pig Vaccine Market in European countries.
- Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
- Middle East and Africa Examining market dynamics in the Middle East and African regions.
- Latin America Covering market trends and developments in countries across Latin America.
Key Players
The major players in the Pig Vaccine Market are
- Zoetis Inc.
- Boehringer Ingelheim GmbH
- Elanco (Eli Lilly and Company)
- Merck & Co., Inc.
- Hipra
- Ceva Santé Animale
- Vetoquinol
- Indian Immunologicals Ltd.
- BiogénesisBagó
- Phibro Animal Health
- KM Biologics
- Virbac
- Bayer AG
- Bimeda Animal Health
- Sanofi S.A
Report Scope
Report Attributes | Details |
---|---|
Study Period | 2020-2031 |
Base Year | 2023 |
Forecast Period | 2024-2031 |
Historical Period | 2020-2022 |
Unit | Value (USD Billion) |
Key Companies Profiled | Zoetis Inc., Boehringer Ingelheim GmbH, Elanco (Eli Lilly and Company), Merck & Co., Inc., Hipra, Vetoquinol, Indian Immunologicals Ltd., BiogénesisBagó, Phibro Animal Health, Virbac |
Segments Covered | By Technology, By Disease Indication, By End User, And By Geography. |
Customization scope | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.